Recent studies show that pentraxin 3 has emerged as a promising marker for diagnosing respiratory tract infections.[9] Therefore, we performed a meta-analysis of eligible clinical studies to assess diagnostic value of pentraxin 3 in respiratory tract infections and ventilator-associated pneumonia (VAP). This evidence concerns the gene PTX3 and ventilator-associated pneumonia.